The current AGE market cap is 12.62M. The company's latest EPS is USD -0.2757 and P/E is -1.20.
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 12k | 9k | 8k | 10k | 9k |
Operating Income | -1.59M | -1.55M | -1.78M | -2.16M | -1.89M |
Net Income | -2.62M | -2.44M | -2.7M | -3.28M | -2.67M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.4M | 1.73M | 1.87M | 144k | 34k |
Operating Income | -11.25M | -12.56M | -10.67M | -8.04M | -6.98M |
Net Income | -7.5M | -12.15M | -10.87M | -8.68M | -10.46M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.58M | 2.01M | 3.24M | 12.53M | 12.28M |
Total Liabilities | 15.84M | 17.16M | 20.56M | 32.54M | 34.57M |
Total Equity | -13.26M | -15.15M | -17.32M | -20.01M | -22.3M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.67M | 7.44M | 3.93M | 3.15M | 3.24M |
Total Liabilities | 2.44M | 4.83M | 9.32M | 15.03M | 20.56M |
Total Equity | 8.23M | 2.62M | -5.4M | -11.88M | -17.32M |
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.38M | -4.62M | -5.94M | -1.87M | -3.88M |
Investing | N/A | N/A | N/A | -10M | -10M |
Financing | 3.5M | 4.5M | 6M | 11.5M | 13.5M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8M | -10.16M | -7.82M | -7.86M | -5.94M |
Investing | 1.33M | -361k | -20k | 666k | N/A |
Financing | 6M | 6.27M | 5.96M | 7.25M | 6M |
Market Cap | 12.62M |
Price to Earnings Ratio | -1.20 |
Price to Sales Ratio | 366.67 |
Price to Cash Ratio | 19.41 |
Price to Book Ratio | -0.72 |
Dividend Yield | - |
Shares Outstanding | 37.95M |
Average Volume (1 week) | 90.59k |
Average Volume (1 Month) | 746.74k |
52 Week Change | -39.56% |
52 Week High | 1.00 |
52 Week Low | 0.3321 |
Spread (Intraday) | 0.03 (8.96%) |
Company Name | AgeX Therapeutics Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.agexinc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.